PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[genisi]

Press Release Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Added to Russell 3000(R) Index
Tuesday June 26, 11:24 am ET

CARMIEL, Israel, June 26 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: PLX - News) today announced that its shares have been added to the broad market Russell 3000® Index. The Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes following the close of the U.S. markets on Friday, June 22.

Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index, as well as the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Dr. David Aviezer, President and Chief Executive Officer of Protalix, stated, "Our addition to the Russell index is a reflection of the progress we have made since we listed our shares on the American Stock Exchange. Our recent receipt of FDA approval to launch phase III clinical trials of prGCD represents a significant milestone for Protalix and gives us great confidence in the future of the Company. We believe that inclusion in this index will help increase our visibility among investors and contribute to our efforts to increase shareholder value."
snip